Troubled Realm Therapeutics Selling Assets, Delisting From London AIM

US-based, UK-listed biotech says it is talking with 'interested parties' including those considering making an offer for the business.

AssetManagement
Clinical Failures Have Forced Realm To Seek Buyers • Source: Shutterstock

More from Strategy

More from Business